Developer docs
API playgroundTry for free, no card

Search company profiles

Cantabria Labs Difa Cooper

Full company profile

uuid02lynro

Namestring
Cantabria Labs Difa Cooper
Legal namestring
Difa Cooper SpA
Company typeenum
Private
Founded yearint
1959
Descriptiontext

Cantabria Labs Difa Cooper (legal name: Difa Cooper SpA) is an Italian dermatology company founded in 1959 and headquartered in Caronno Pertusella (Varese), operating as a wholly owned subsidiary (Socio Unico) of the Spanish group Industrial Farmacéutica Cantabria S.A. The company develops, manufactures, and distributes a broad portfolio of dermatological products organised into four categories: drugs (farmaci), cosmetics (cosmetici), food supplements (integratori alimentari), and medical devices (dispositivi medici). Two flagship sub-brands anchor the portfolio — Heliocare for photoprotection built on the proprietary FERNBLOCK® (Polypodium leucotomos) extract, and Endocare for anti-aging skincare built on SCA® and RETINSPHERE® technologies — alongside condition-specific lines addressing acne (Biretix), rosacea (Eutrosis), hair loss (GFm, Adenosil, Tricostimolin-A), scar treatment (Vicutix Scar), and supportive oncology skincare (Onco Quality Life).

Underpinning the portfolio are more than 20 proprietary, trademarked technologies spanning active ingredients, delivery systems (e.g., Glicosfere, Melatosphere, Polyvinyl A), and biotech-derived peptides (MIMICKING GROWTH FACTORS®), supported by over 80 scientific studies, with FERNBLOCK® positioned as a full-spectrum (UVB, UVA, visible, IR) photoprotectant. Distribution is exclusively through the Italian pharmacy and parapharmacy channel, supported by what the company describes as the broadest commercial medical information network in Italian dermatology — a field force that engages daily with physicians, pharmacists, and patients — and by an online pharmacy locator. The revenue model is a one-time sale across each product category, with no disclosed subscription, SaaS, or licensing monetisation. Commercial activity is complemented by a CSR partnership with LILT (Lega Italiana per la Lotta contro i Tumori) for free mole screening using Heliocare products. The Italian entity has a share capital of €750,000 and is subject to direction and coordination by its Spanish parent.

Short descriptiontext

Cantabria Labs Difa Cooper is an Italian dermatology company, founded in 1959 and wholly owned by Spain's Industrial Farmacéutica Cantabria, that develops and distributes drugs, cosmetics, food supplements, and medical devices exclusively through Italian pharmacies, anchored by the Heliocare and Endocare sub-brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCaronno Pertusella, Italy
HQ citystring
Caronno Pertusella
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dermatological products, skincare cosmetics, pharmaceutical drugs, food supplements, medical devices
Industry4 codes
PRIMARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
Product category
Dermatological Products
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Cosmetics (Cosmetici)
TypeOne Time License
Description

Topical skincare products including creams, gels, lotions, masks, and shampoos for face, body, hair, and nails. Sold exclusively through pharmacies and parapharmacies.

cantabrialabsdifacooper.it
2Drugs/Medicines (Farmaci)
TypeOne Time License
Description

Prescription and over-the-counter pharmaceutical products for dermatological conditions. Includes acne treatments, hair loss treatments, and other therapeutic products.

cantabrialabsdifacooper.it
3Food Supplements (Integratori alimentari)
TypeOne Time License
Description

Dietary supplements in capsule, tablet, and stick formats for skin, hair, and nail health. Contains natural extracts, vitamins, minerals, and amino acids.

cantabrialabsdifacooper.it
4Medical Devices (Dispositivi medici)
TypeOne Time License
Description

Medical devices for scar treatment, wound healing, skin barrier protection, and other dermatological applications. Includes products like VICUTIX SCAR, RETINCARE, and ECOCEL.

cantabrialabsdifacooper.it
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Heliocare
Description

Photoprotection product line featuring Fernblock technology, available as topical sunscreens and oral supplements.

cantabrialabsdifacooper.it
+1 more record
Core offering1 text field

Cantabria Labs Difa Cooper develops, manufactures and distributes a dermatology-focused portfolio comprising drugs (farmaci), cosmetics (cosmetici), food supplements (integratori alimentari) and medical devices (dispositivi medici). Flagship ranges include the HELIOCARE photoprotection sub-brand built around the proprietary Fernblock technology (Polypodium leucotomos extract) and the ENDOCARE anti-aging sub-brand built around SCA growth factors and Retinsphere technology. All products are sold exclusively through Italian pharmacies and parapharmacies, marketed through a national medical information network that engages daily with dermatologists, pharmacists and patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • More than 80 scientific studies supporting Fernblock technology efficacy
+1 more record
Product overview1 text field

Cantabria Labs Difa Cooper is a dermatological company operating since 1959, offering a comprehensive portfolio of topical products organized into four main categories: Cosmetics (cosmetici), Drugs (farmaci), Food Supplements (integratori alimentari), and Medical Devices (dispositivi medici). Key product sub-brands include HELIOCARE (photoprotection with SPF and Fernblock technology) and ENDOCARE (anti-aging with retinsphere technology). The product range addresses various skin concerns including acne, rosacea, psoriasis, dermatitis, actinic damage, hair loss, and nail problems. Distribution is exclusively through pharmacies and parapharmacies in Italy. The company employs proprietary technologies including Fernblock, Retinsphere, MIMICKING GROWTH FACTORS, NUCLEDIL, 1-3 ATODINA, SCA, and others developed through decades of dermatological research.

Product and service38 records
1HELIOCARE
CategorySun protection / photoprotection sub-brand (cosmetics and food supplements).
Description

Sub-brand of topical sunscreens (SPF 50+, SPF 100+) and oral photoprotection supplements built around the proprietary FERNBLOCK® Polypodium leucotomos extract, providing full-spectrum protection against UVB, UVA, visible light and infrared radiation. Sold through Italian pharmacies and parapharmacies; marketed to dermatologists, pharmacists and end consumers concerned with sun damage, photoaging, oxidative stress and skin cancer prevention.

2ENDOCARE
CategoryAnti-aging skincare sub-brand (cosmetics).
Description

Anti-aging skincare line leveraging proprietary RETINSPHERE® (retinoid-based) and SCA® (growth factor) technologies for skin regeneration, renewal and wrinkle reduction. Sold in Italian pharmacies for adult consumers seeking clinically backed anti-aging solutions.

3GFm Densactive
CategoryHair care cosmetic.
Description

Topical gel cosmetic indicated for all forms of hair loss, using MIMICKING GROWTH FACTORS® technology to help prolong the anagen (growth) phase. Sold through Italian pharmacies.

4GFm Lozione
CategoryHair care cosmetic.
Description

Topical solution with a high concentration of the GFM complex of polypeptides, indicated as coadjuvant in all forms of hair loss. Pharmacy-channel cosmetic.

5ADENOSIL Shampoo
CategoryHair care cosmetic.
Description

Delicate anti-hair-loss shampoo suitable for all hair types and daily use, featuring 1-3 ATODINA® technology (Adenosine, Ornithine, Taurine complex) to normalize the scalp. Pharmacy cosmetic.

6ADENOSIL Maschera
CategoryHair care cosmetic.
Description

Restructuring mask for dry, damaged hair, with 1-3 ATODINA® technology to help counteract hair loss and increase hair diameter. Sold in Italian pharmacies.

7TRICOSTIMOLIN-A
CategoryHair care cosmetic.
Description

Adjuvant cosmetic treatment for physiological hair regrowth combining oligotherapy trace elements to support hair and scalp trophism. Pharmacy cosmetic.

8NIPON E Ultra
CategoryFood supplement (capsules/stick formats).
Description

Food supplement combining flaxseed oil, evening primrose oil and zinc to support physiological skin trophism and the maintenance of normal hair. Distributed through Italian pharmacies and parapharmacies.

9DIECI PLUS
CategoryFood supplement (capsules/stick formats).
Description

Food supplement of amino acids, zinc, ornithine and taurine supporting the maintenance of normal hair, nails and skin. Distributed through Italian pharmacies.

10HELIOCARE 360° Gel Cream 100+
CategorySun protection cosmetic.
Description

High-protection facial sunscreen (SPF 100+) featuring FERNBLOCK® technology for advanced dermatological photoprotection. Pharmacy cosmetic.

11HELIOCARE 360° Capsule
CategoryFood supplement.
Description

Oral food-supplement capsules featuring FERNBLOCK® technology for systemic photoprotection, complementing topical sunscreen use. Pharmacy food supplement.

12HELIOCARE 360° A-R Emulsion SPF 50+
CategorySun protection cosmetic.
Description

SPF 50+ sunscreen emulsion for sensitive skin prone to rosacea or redness, combining high photoprotection with anti-redness properties. Pharmacy cosmetic.

13EUTROSIS
CategoryFacial care cosmetic.
Description

Cosmetic line for rosacea- and redness-prone skin conditions, leveraging proprietary NUCLEDIL® and related actives. Distributed through Italian pharmacies.

14BIRETIX
CategoryAcne-care cosmetic.
Description

Cosmetic line for acne-prone skin (also referenced as a food supplement for skin support). Sold through Italian pharmacies.

15P.O.L.
CategoryBarrier / hydration cosmetic and medical device.
Description

Product line built on patented P.O.L.® technology for skin-barrier repair and hydration, offered both as a cosmetic and as a medical device in the corresponding category page.

16ECOCEL Unghie (nails)
CategoryNail care cosmetic / medical device.
Description

Nail treatment product available in cosmetic and medical device formulations. Sold in Italian pharmacies.

17AMPCARE
CategoryFood supplement / medical device.
Description

Product offered both as a food supplement and as a medical device for specific dermatological applications. Pharmacy channel.

18Onco Quality Life
CategoryOncology-support cosmetic.
Description

Cosmetic line for oncology patients to support skin care during and after cancer treatments. Distributed through Italian pharmacies.

19VICUTIX SCAR
CategoryMedical device (scar care).
Description

Medical device for scar treatment and reduction. Distributed exclusively through Italian pharmacies.

20RETINCARE
CategoryMedical device (dermatological care).
Description

Medical device for specific dermatological applications, complementing the RETINSPHERE®-based anti-aging range. Pharmacy channel.

21ACTIXICAM
CategoryMedical device.
Description

Medical device for dermatological applications. Sold through Italian pharmacies.

22MASK
CategoryMedical device.
Description

Dermatological medical device product, sold exclusively through Italian pharmacies.

23MASKRYM
CategoryMedical device.
Description

Dermatological medical device product, sold exclusively through Italian pharmacies.

24CAREDIESSE (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.

25CAREFINAST (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.

26CAREXIDIL (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category, used in hair-related indications. Distributed through Italian pharmacies.

27FLUTICREM (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.

28IMUNOCARE (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.

29ISOTRETINOINA (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category, used in acne indications. Distributed through Italian pharmacies.

30NEBIOTIN (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category, used in hair/nail indications. Distributed through Italian pharmacies.

31TRANS-VER-SAL (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.

32VEREGEN (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.

33ZINDACLIN (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category, used in acne indications. Distributed through Italian pharmacies.

34ZORIAS (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.

35VELOS (farmaco)
CategoryPharmaceutical (farmaco).
Description

Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.

36AGA PLUS (integratore alimentare)
CategoryFood supplement.
Description

Food supplement supporting hair well-being in androgenetic alopecia and related conditions, distributed through Italian pharmacies.

37NIPON E (integratore alimentare)
CategoryFood supplement.
Description

Food supplement variant of the NIPON E line for skin and hair nutrition, sold through Italian pharmacies.

38DIECI PLUS (integratore alimentare)
CategoryFood supplement.
Description

Food supplement supporting hair, skin and nails, sold through Italian pharmacies.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for health awareness initiatives including free mole screening programs. Difa Cooper provides Heliocare sunscreen products to support LILT's skin cancer prevention campaigns. This represents a corporate social responsibility partnership focused on dermatological health education and prevention.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Italian dermo-cosmetics company targeting sensitive, allergic, and reactive skin with pharmacy-channel distribution; direct domestic competitor with overlapping customer segments (special populations, sensitive skin).

2Rilastil (Istituto Ganassini)
TypeDirect peer
Description

Italian dermo-cosmetics brand with a strong pharmacy-channel presence across skincare, sun care, and body care—directly comparable in go-to-market (Italian pharmacy exclusive distribution) and dermatology positioning.

TypeDirect peer
Description

Italian pharmaceutical company with a dedicated dermatology, hair-care, and gut-skin portfolio distributed through pharmacy channels—comparable Italian-market dermatology peer.

TypeDirect peer
Description

Global dermatology company with both Rx and skincare/consumer franchises serving dermatologists and patients; comparable in prescription dermatology pipeline and OTC/consumer dermatology assets.

TypeBroad incumbent
Description

Beiersdorf's medical-skincare brand with a portfolio spanning acne, atopic skin, sun protection, and anti-aging—directly overlapping therapeutic dermatology categories and pharmacy distribution.

TypeDirect peer
Description

NAOS's dermo-cosmetics brand focused on biology-driven dermatological skincare in pharmacy channels—closely comparable in positioning around dermatology-first formulations and pharmacy distribution.

TypeBroad incumbent
Description

Pierre Fabre's dermo-cosmetics brand centered on thermal-spring water and sensitive-skin dermatology; broadly comparable in pharmacy-channel, dermatologist-recommended dermatology positioning.

TypeDirect peer
Description

Spanish-based dermo-cosmetics leader with a portfolio anchored in photoprotection and dermatological skincare, sold through pharmacy channels with overlapping Italian and European distribution—closely aligned in business model and product mix.

TypeDirect peer
Description

Spanish dermatology-focused pharmaceutical company with Rx and OTC medical-dermatology products across Europe; comparable as a Southern-European dermatology specialty pharma with a similar physician-driven model.

TypeBroad incumbent
Description

L'Oréal's global dermatological beauty division and the leading pharmacy-channel dermo-cosmetics brand; competes across sensitive skin, acne, and photoprotection—the same core verticals where Cantabria Labs Difa Cooper operates.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature23 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cantabria Labs Difa Cooper

Dermatological Productscantabrialabsdifacooper.it

Cantabria Labs Difa Cooper is an Italian dermatology company, founded in 1959 and wholly owned by Spain's Industrial Farmacéutica Cantabria, that develops and distributes drugs, cosmetics, food supplements, and medical devices exclusively through Italian pharmacies, anchored by the Heliocare and Endocare sub-brands.

What Cantabria Labs Difa Cooper does

Cantabria Labs Difa Cooper (legal name: Difa Cooper SpA) is an Italian dermatology company founded in 1959 and headquartered in Caronno Pertusella (Varese), operating as a wholly owned subsidiary (Socio Unico) of the Spanish group Industrial Farmacéutica Cantabria S.A. The company develops, manufactures, and distributes a broad portfolio of dermatological products organised into four categories: drugs (farmaci), cosmetics (cosmetici), food supplements (integratori alimentari), and medical devices (dispositivi medici). Two flagship sub-brands anchor the portfolio — Heliocare for photoprotection built on the proprietary FERNBLOCK® (Polypodium leucotomos) extract, and Endocare for anti-aging skincare built on SCA® and RETINSPHERE® technologies — alongside condition-specific lines addressing acne (Biretix), rosacea (Eutrosis), hair loss (GFm, Adenosil, Tricostimolin-A), scar treatment (Vicutix Scar), and supportive oncology skincare (Onco Quality Life).

Underpinning the portfolio are more than 20 proprietary, trademarked technologies spanning active ingredients, delivery systems (e.g., Glicosfere, Melatosphere, Polyvinyl A), and biotech-derived peptides (MIMICKING GROWTH FACTORS®), supported by over 80 scientific studies, with FERNBLOCK® positioned as a full-spectrum (UVB, UVA, visible, IR) photoprotectant. Distribution is exclusively through the Italian pharmacy and parapharmacy channel, supported by what the company describes as the broadest commercial medical information network in Italian dermatology — a field force that engages daily with physicians, pharmacists, and patients — and by an online pharmacy locator. The revenue model is a one-time sale across each product category, with no disclosed subscription, SaaS, or licensing monetisation. Commercial activity is complemented by a CSR partnership with LILT (Lega Italiana per la Lotta contro i Tumori) for free mole screening using Heliocare products. The Italian entity has a share capital of €750,000 and is subject to direction and coordination by its Spanish parent.

Cantabria Labs Difa Cooper firmographics

Firmographics
Name
Cantabria Labs Difa Cooper
Legal name
Difa Cooper SpA
Website
https://cantabrialabsdifacooper.it
Company type
Private
Founded year
1959
Operating status
Operating
Headcount range
101–250 employees
Short description
Cantabria Labs Difa Cooper is an Italian dermatology company, founded in 1959 and wholly owned by Spain's Industrial Farmacéutica Cantabria, that develops and distributes drugs, cosmetics, food supplements, and medical devices exclusively through Italian pharmacies, anchored by the Heliocare and Endocare sub-brands.
Ownership category
akta.pro rank

Cantabria Labs Difa Cooper industry classification

Industry
Product category
Dermatological Products
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)

Keywords

  • Dermatological products
  • Skincare cosmetics
  • Pharmaceutical drugs
  • Food supplements
  • Medical devices

Where Cantabria Labs Difa Cooper is headquartered

Location

Headquarters

HQ city
Caronno Pertusella
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Cantabria Labs Difa Cooper business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Cosmetics (Cosmetici): Topical skincare products including creams, gels, lotions, masks, and shampoos for face, body, hair, and nails. Sold exclusively through pharmacies and parapharmacies.
  2. Drugs/Medicines (Farmaci): Prescription and over-the-counter pharmaceutical products for dermatological conditions. Includes acne treatments, hair loss treatments, and other therapeutic products.
  3. Food Supplements (Integratori alimentari): Dietary supplements in capsule, tablet, and stick formats for skin, hair, and nail health. Contains natural extracts, vitamins, minerals, and amino acids.
  4. Medical Devices (Dispositivi medici): Medical devices for scar treatment, wound healing, skin barrier protection, and other dermatological applications. Includes products like VICUTIX SCAR, RETINCARE, and ECOCEL.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Cantabria Labs Difa Cooper product offering

Product offering

Core offering

Cantabria Labs Difa Cooper develops, manufactures and distributes a dermatology-focused portfolio comprising drugs (farmaci), cosmetics (cosmetici), food supplements (integratori alimentari) and medical devices (dispositivi medici). Flagship ranges include the HELIOCARE photoprotection sub-brand built around the proprietary Fernblock technology (Polypodium leucotomos extract) and the ENDOCARE anti-aging sub-brand built around SCA growth factors and Retinsphere technology. All products are sold exclusively through Italian pharmacies and parapharmacies, marketed through a national medical information network that engages daily with dermatologists, pharmacists and patients.

Product overview

Cantabria Labs Difa Cooper is a dermatological company operating since 1959, offering a comprehensive portfolio of topical products organized into four main categories: Cosmetics (cosmetici), Drugs (farmaci), Food Supplements (integratori alimentari), and Medical Devices (dispositivi medici). Key product sub-brands include HELIOCARE (photoprotection with SPF and Fernblock technology) and ENDOCARE (anti-aging with retinsphere technology). The product range addresses various skin concerns including acne, rosacea, psoriasis, dermatitis, actinic damage, hair loss, and nail problems. Distribution is exclusively through pharmacies and parapharmacies in Italy. The company employs proprietary technologies including Fernblock, Retinsphere, MIMICKING GROWTH FACTORS, NUCLEDIL, 1-3 ATODINA, SCA, and others developed through decades of dermatological research.

Differentiator

Problem solved

Functional benefit

Brands

  • Heliocare: Photoprotection product line featuring Fernblock technology, available as topical sunscreens and oral supplements.
  • Endocare

Products and services

  • HELIOCARE Sub-brand of topical sunscreens (SPF 50+, SPF 100+) and oral photoprotection supplements built around the proprietary FERNBLOCK® Polypodium leucotomos extract, providing full-spectrum protection against UVB, UVA, visible light and infrared radiation. Sold through Italian pharmacies and parapharmacies; marketed to dermatologists, pharmacists and end consumers concerned with sun damage, photoaging, oxidative stress and skin cancer prevention.
  • ENDOCARE Anti-aging skincare line leveraging proprietary RETINSPHERE® (retinoid-based) and SCA® (growth factor) technologies for skin regeneration, renewal and wrinkle reduction. Sold in Italian pharmacies for adult consumers seeking clinically backed anti-aging solutions.
  • GFm Densactive Topical gel cosmetic indicated for all forms of hair loss, using MIMICKING GROWTH FACTORS® technology to help prolong the anagen (growth) phase. Sold through Italian pharmacies.
  • GFm Lozione Topical solution with a high concentration of the GFM complex of polypeptides, indicated as coadjuvant in all forms of hair loss. Pharmacy-channel cosmetic.
  • ADENOSIL Shampoo Delicate anti-hair-loss shampoo suitable for all hair types and daily use, featuring 1-3 ATODINA® technology (Adenosine, Ornithine, Taurine complex) to normalize the scalp. Pharmacy cosmetic.
  • ADENOSIL Maschera Restructuring mask for dry, damaged hair, with 1-3 ATODINA® technology to help counteract hair loss and increase hair diameter. Sold in Italian pharmacies.
  • TRICOSTIMOLIN-A Adjuvant cosmetic treatment for physiological hair regrowth combining oligotherapy trace elements to support hair and scalp trophism. Pharmacy cosmetic.
  • NIPON E Ultra Food supplement combining flaxseed oil, evening primrose oil and zinc to support physiological skin trophism and the maintenance of normal hair. Distributed through Italian pharmacies and parapharmacies.
  • DIECI PLUS Food supplement of amino acids, zinc, ornithine and taurine supporting the maintenance of normal hair, nails and skin. Distributed through Italian pharmacies.
  • HELIOCARE 360° Gel Cream 100+ High-protection facial sunscreen (SPF 100+) featuring FERNBLOCK® technology for advanced dermatological photoprotection. Pharmacy cosmetic.
  • HELIOCARE 360° Capsule Oral food-supplement capsules featuring FERNBLOCK® technology for systemic photoprotection, complementing topical sunscreen use. Pharmacy food supplement.
  • HELIOCARE 360° A-R Emulsion SPF 50+ SPF 50+ sunscreen emulsion for sensitive skin prone to rosacea or redness, combining high photoprotection with anti-redness properties. Pharmacy cosmetic.
  • EUTROSIS Cosmetic line for rosacea- and redness-prone skin conditions, leveraging proprietary NUCLEDIL® and related actives. Distributed through Italian pharmacies.
  • BIRETIX Cosmetic line for acne-prone skin (also referenced as a food supplement for skin support). Sold through Italian pharmacies.
  • P.O.L. Product line built on patented P.O.L.® technology for skin-barrier repair and hydration, offered both as a cosmetic and as a medical device in the corresponding category page.
  • ECOCEL Unghie (nails) Nail treatment product available in cosmetic and medical device formulations. Sold in Italian pharmacies.
  • AMPCARE Product offered both as a food supplement and as a medical device for specific dermatological applications. Pharmacy channel.
  • Onco Quality Life Cosmetic line for oncology patients to support skin care during and after cancer treatments. Distributed through Italian pharmacies.
  • VICUTIX SCAR Medical device for scar treatment and reduction. Distributed exclusively through Italian pharmacies.
  • RETINCARE Medical device for specific dermatological applications, complementing the RETINSPHERE®-based anti-aging range. Pharmacy channel.
  • ACTIXICAM Medical device for dermatological applications. Sold through Italian pharmacies.
  • MASK Dermatological medical device product, sold exclusively through Italian pharmacies.
  • MASKRYM Dermatological medical device product, sold exclusively through Italian pharmacies.
  • CAREDIESSE (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
  • CAREFINAST (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
  • CAREXIDIL (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category, used in hair-related indications. Distributed through Italian pharmacies.
  • FLUTICREM (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
  • IMUNOCARE (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
  • ISOTRETINOINA (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category, used in acne indications. Distributed through Italian pharmacies.
  • NEBIOTIN (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category, used in hair/nail indications. Distributed through Italian pharmacies.
  • TRANS-VER-SAL (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
  • VEREGEN (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
  • ZINDACLIN (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category, used in acne indications. Distributed through Italian pharmacies.
  • ZORIAS (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
  • VELOS (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
  • AGA PLUS (integratore alimentare) Food supplement supporting hair well-being in androgenetic alopecia and related conditions, distributed through Italian pharmacies.
  • NIPON E (integratore alimentare) Food supplement variant of the NIPON E line for skin and hair nutrition, sold through Italian pharmacies.
  • DIECI PLUS (integratore alimentare) Food supplement supporting hair, skin and nails, sold through Italian pharmacies.

Quantifiable outcome

  • More than 80 scientific studies supporting Fernblock technology efficacy
  • +1 more outcomes

Companies that use Cantabria Labs Difa Cooper

Customer profile

Segments4 records

Ideal customer profiles3 records

Cantabria Labs Difa Cooper technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature23 records

Cantabria Labs Difa Cooper partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • LILT (Lega Italiana per la Lotta contro i Tumori)minorStrategic or Co-development PartnerPartnership for health awareness initiatives including free mole screening programs. Difa Cooper provides Heliocare sunscreen products to support LILT's skin cancer prevention campaigns. This represents a corporate social responsibility partnership focused on dermatological health education and prevention.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Cantabria Labs Difa Cooper competitors and assessment

Company assessment

Direct peers

  • Bionike: Italian dermo-cosmetics company targeting sensitive, allergic, and reactive skin with pharmacy-channel distribution; direct domestic competitor with overlapping customer segments (special populations, sensitive skin).
  • Rilastil (Istituto Ganassini): Italian dermo-cosmetics brand with a strong pharmacy-channel presence across skincare, sun care, and body care—directly comparable in go-to-market (Italian pharmacy exclusive distribution) and dermatology positioning.
  • Giuliani: Italian pharmaceutical company with a dedicated dermatology, hair-care, and gut-skin portfolio distributed through pharmacy channels—comparable Italian-market dermatology peer.
  • Galderma: Global dermatology company with both Rx and skincare/consumer franchises serving dermatologists and patients; comparable in prescription dermatology pipeline and OTC/consumer dermatology assets.
  • Bioderma (NAOS): NAOS's dermo-cosmetics brand focused on biology-driven dermatological skincare in pharmacy channels—closely comparable in positioning around dermatology-first formulations and pharmacy distribution.
  • ISDIN: Spanish-based dermo-cosmetics leader with a portfolio anchored in photoprotection and dermatological skincare, sold through pharmacy channels with overlapping Italian and European distribution—closely aligned in business model and product mix.
  • Almirall: Spanish dermatology-focused pharmaceutical company with Rx and OTC medical-dermatology products across Europe; comparable as a Southern-European dermatology specialty pharma with a similar physician-driven model.

Broad incumbents

  • Eucerin (Beiersdorf): Beiersdorf's medical-skincare brand with a portfolio spanning acne, atopic skin, sun protection, and anti-aging—directly overlapping therapeutic dermatology categories and pharmacy distribution.
  • Avène (Pierre Fabre Dermatologie): Pierre Fabre's dermo-cosmetics brand centered on thermal-spring water and sensitive-skin dermatology; broadly comparable in pharmacy-channel, dermatologist-recommended dermatology positioning.
  • La Roche-Posay (L'Oréal Dermatological Beauty): L'Oréal's global dermatological beauty division and the leading pharmacy-channel dermo-cosmetics brand; competes across sensitive skin, acne, and photoprotection—the same core verticals where Cantabria Labs Difa Cooper operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Cantabria Labs Difa Cooper social profiles

Digital presence

Cantabria Labs Difa Cooper financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cantabria Labs Difa Cooper leadership team

Management profile

Number of profiles

Cantabria Labs Difa Cooper funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cantabria Labs Difa Cooper M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cantabria Labs Difa Cooper

What does Cantabria Labs Difa Cooper do?

Cantabria Labs Difa Cooper develops, manufactures and distributes a dermatology-focused portfolio comprising drugs (farmaci), cosmetics (cosmetici), food supplements (integratori alimentari) and medical devices (dispositivi medici). Flagship ranges include the HELIOCARE photoprotection sub-brand built around the proprietary Fernblock technology (Polypodium leucotomos extract) and the ENDOCARE anti-aging sub-brand built around SCA growth factors and Retinsphere technology. All products are sold exclusively through Italian pharmacies and parapharmacies, marketed through a national medical information network that engages daily with dermatologists, pharmacists and patients.

Is Cantabria Labs Difa Cooper a public or private company?

Cantabria Labs Difa Cooper is a private company. It is classified as corporate owned and is currently operating.

When was Cantabria Labs Difa Cooper founded?

Cantabria Labs Difa Cooper was founded in 1959. It employs 101 to 250 people.

Where is Cantabria Labs Difa Cooper based?

Cantabria Labs Difa Cooper is headquartered in Caronno Pertusella, Italy, in the Europe region.

How does Cantabria Labs Difa Cooper make money?

Four revenue lines are on record. Cosmetics (Cosmetici) is the primary driver. The others are drugs/Medicines (Farmaci), food Supplements (Integratori alimentari) and medical Devices (Dispositivi medici).

Who are Cantabria Labs Difa Cooper's main competitors?

Direct peers on record are Bionike, Rilastil (Istituto Ganassini), Giuliani, Galderma, Bioderma (NAOS), ISDIN and Almirall. Broad incumbents are Eucerin (Beiersdorf), Avène (Pierre Fabre Dermatologie) and La Roche-Posay (L'Oréal Dermatological Beauty).

Does Cantabria Labs Difa Cooper have an API?

No public API is recorded for Cantabria Labs Difa Cooper.

What industry is Cantabria Labs Difa Cooper in?

Cantabria Labs Difa Cooper's product category is Dermatological Products. Its primary akta.pro industry code is HLAIACAL, Dermatology Specialty Pharmaceuticals, with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals